Charles Schwab Investment Management Inc Lexicon Pharmaceuticals, Inc. Transaction History
Charles Schwab Investment Management Inc
- $527 Billion
- Q4 2024
A detailed history of Charles Schwab Investment Management Inc transactions in Lexicon Pharmaceuticals, Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 1,191,091 shares of LXRX stock, worth $845,674. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,191,091
Previous 1,417,295
15.96%
Holding current value
$845,674
Previous $2.23 Million
60.4%
% of portfolio
0.0%
Previous 0.0%
Shares
30 transactions
Others Institutions Holding LXRX
# of Institutions
133Shares Held
245MCall Options Held
52KPut Options Held
178K-
Artal Group S.A. Luxembourg, N4136MShares$96.7 Million100.0% of portfolio
-
Siren, L.L.C. New York, NY38.9MShares$27.6 Million1.27% of portfolio
-
Black Rock Inc. New York, NY9.89MShares$7.02 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA9.88MShares$7.02 Million0.0% of portfolio
-
Steven Cohen Point72 Asset Management, L.P. | Stamford, Ct8.99MShares$6.38 Million0.02% of portfolio
About LEXICON PHARMACEUTICALS, INC.
- Ticker LXRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 188,726,000
- Market Cap $134M
- Description
- Lexicon Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of pharmaceutical products. Its orally-delivered small molecule drug candidates under development comprise Sotagliflozin that completed Phase III clinical trials for the for the treatment of heart failure and type 1 diabetes; ...